Top Markets
Coin of the day
Algorae Pharmaceuticals Limited Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

1AI
Rang in Aktien #30733
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Aktienkurs
$0.00775813
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$15.73M
Veränderung (1 Tag)
-8.33%
Veränderung (1 Jahr)
71.69%
Land
AU
Handel Algorae Pharmaceuticals Limited (1AI)

Kategorie

Kursverlauf für Algorae Pharmaceuticals Limited (1AI)
Höchster Schlusskurs: $0.01 am 2026-08-01

Niedrigster Schlusskurs: $0.01 am 2023-08-01
Kursverlauf der Aktie von Algorae Pharmaceuticals Limited von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -10.71%
2025 104.60%
2024 -39.97%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$116.15 -20.20%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE